LivingGLP1
parallel randomized trial

S002957

Design

Randomized
33
Start year
2016
Treatment
12 weeks, follow-up 12 weeks
Countries
Japan (6 sites)
Sponsor
(not reported)
Eligibility
age 20 or more; HbA1c 6.0 to <9.0%; liraglutide 0.9 mg for over 3 months

Conduct and analysis

Blinding
open label
Sequence generation
computer
Allocation concealment
central
Outcome adjudication
not reported
Primary estimand
not stated
Analysis population
completers
Missing data
completers only

Arms

ArmTreatmentBackgroundRandomizedAnalyzedCompleted treatment
A1liraglutide
Lira group
prior oral agents and insulin continued; lifestyle: standard1615
A2Dulaglutide 0.75 mg subcutaneous once weekly
Dula group
prior oral agents and insulin continued; lifestyle: standard1716

Baseline characteristics

As printed in the trial reports or registry, per arm or for the whole trial.
CharacteristicStatisticLira group
A1
Dulaglutide 0.75 mg subcutaneous once weekly
A2
agemean (years)61.262.7
agesd (years)12.811.2
diabetes durationmean (years)18.518.6
diabetes durationsd (years)9.810.6
femalen810
hba1cmean (percent)7.47.7
hba1csd (percent)0.50.8
insulin usepercent50.058.8
metformin usepercent68.888.2
other alpha glucosidase inhibitor usepercent25.017.6
other glinide usepercent18.811.8
other sulfonylurea usepercent18.847.1
other thiazolidinedione usepercent12.50.0
sglt2i usepercent37.517.6
weightmean (kg)70.771.2
weightsd (kg)11.918.1

Results

8 adjudicated result lines, grouped by outcome. Open an outcome to see its values.
HbA1c change (2 lines; O01)
WeekArmStatisticEstimateSE or SD95% CIEvents / NDetail
12A1change0.05 percent0.41not stated; other; R0007926:Table 3
12A2change0.00 percent0.68not stated; other; R0007926:Table 3
Body weight change in kilograms (diabetes) (2 lines; O02)
WeekArmStatisticEstimateSE or SD95% CIEvents / NDetail
12A1change kgnot stated; other; R0007926:Table 3
12A2change kgnot stated; other; R0007926:Table 3
Health related quality of life total score (any instrument) (4 lines; O24C)
WeekArmStatisticEstimateSE or SD95% CIEvents / NDetail
12A1change-3.7 points6.915not stated; completers; R0007926:Table 2
12A1change0.1 points4.715not stated; completers; R0007926:Table 2
12A2change8.9 points15.116not stated; completers; R0007926:Table 2
12A2change4.9 points5.216not stated; completers; R0007926:Table 2